ACAD
ACADIA Pharmaceuticals Inc.
NASDAQ · USHealthcareBiotechnology
$25.09-1.99%
Price as of Jul 20, 2026
ACAD profitability
ACADIA Pharmaceuticals Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 91.5%
- EBITDA margin
- 11.6%
- EBIT margin
- 7.4%
- Net margin
- 34.3%
- Free cash flow margin
- 19.4%
Returns
- Return on equity
- 30.1%
- Return on assets
- 23.4%
- Return on invested capital
- 6.2%
- Asset turnover
- 0.69x
Cash efficiency
- Cash from operations
- $123.5M
- Cash per share
- $4.97
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.